/Companies

Alitair Pharmaceuticals

Morristown, US · Delaware corporation

Find your way into Alitair Pharmaceuticals

Sign up to see every warm intro you have to Alitair Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Alitair Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

WWWilliam W Howard
William W HowardCEO

Reported raises · per SEC filings

Form D private placements

$1.2M disclosed across 4 of 5 rounds · 2015–2020

▶$35KraisedNov 2020 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert CasaleDirector
  • James E. HoyesExecutive Officer, Director
Offering amount
$31M
Amount sold
$35K
Minimum investment
$5K
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$115KraisedOct 2018 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • William W. HowardExecutive Officer, Director
  • Frank GuarinoExecutive Officer
  • Robert CasaleDirector
  • James E. HoyesExecutive Officer, Director
Offering amount
$32M
Amount sold
$115K
Minimum investment
$5K
First sale
Sep 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MofferedJul 2017 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert CasaleDirector
  • James E. HoyesExecutive Officer, Director
  • William W. HowardExecutive Officer, Director
  • Frank GuarinoExecutive Officer
Offering amount
$5M
Minimum investment
$5K
Placement agents
Network 1 Financial Securities, Inc.
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$100KraisedMar 2017 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • William W HowardExecutive Officer, Director
Offering amount
$3.1M
Amount sold
$100K
Minimum investment
$5K
First sale
Feb 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$910.8KraisedSep 2015 · 18 investors · Pharmaceuticals
Officers, directors & promoters on the filing
  • William W HowardExecutive Officer
Offering amount
$937.5K
Amount sold
$910.8K
Minimum investment
$5K
First sale
Sep 2015
Incorporated
Corporation, Delaware
Federal exemptions
04
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Alitair Pharmaceuticals raised?
Alitair Pharmaceuticals has disclosed $1.2M raised across 4 of its 5 known rounds.
Where is Alitair Pharmaceuticals headquartered?
Alitair Pharmaceuticals is headquartered in Morristown, US.